Regencell Bioscience Holdings Limited – NASDAQ:RGC

Regencell Bioscience Holdings Limited stock price today

$12.31
+7.41
+151.22%
Financial Health
0
1
2
3
4
5
6
7
8
9

Regencell Bioscience Holdings Limited stock price monthly change

+40.00%
month

Regencell Bioscience Holdings Limited stock price quarterly change

+40.00%
quarter

Regencell Bioscience Holdings Limited stock price yearly change

-46.88%
year

Regencell Bioscience Holdings Limited key metrics

Market Cap
62.72M
Enterprise value
4.39B
P/E
-47.46
EV/Sales
1.38
EV/EBITDA
9.47
Price/Sales
1.38
Price/Book
257.62
PEG ratio
0.10
EPS
-0.60
Revenue
N/A
EBITDA
-2.07M
Income
-2.64M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
3.55%
Oper. margin
9.35%
Gross margin
62.33%
EBIT margin
9.35%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Regencell Bioscience Holdings Limited stock price history

Regencell Bioscience Holdings Limited stock forecast

Regencell Bioscience Holdings Limited financial statements

Regencell Bioscience Holdings Limited (NASDAQ:RGC): Profit margin
Mar 2022 0 -1.92K
Jun 2022 0 -1.92K
Mar 2023 0 -1.32K
Jun 2023 0 -2.64M
Regencell Bioscience Holdings Limited (NASDAQ:RGC): Debt to assets
Sep 2022 15548096 0 0%
Dec 2022 15548096 873.78K 5.62%
Mar 2023 12621755 632.32K 5.01%
Jun 2023 12621755 632.32K 5.01%
Regencell Bioscience Holdings Limited (NASDAQ:RGC): Cash Flow
Mar 2022 0 0 0
Jun 2022 0 0 0
Mar 2023 15 0 0
Jun 2023 1.53M 0 0

Regencell Bioscience Holdings Limited alternative data

Regencell Bioscience Holdings Limited (NASDAQ:RGC): Employee count
Aug 2023 13
Sep 2023 13
Oct 2023 13
Nov 2023 13
Dec 2023 12
Jan 2024 12
Feb 2024 12
Mar 2024 12
Apr 2024 12
May 2024 12
Jun 2024 12
Jul 2024 12

Regencell Bioscience Holdings Limited other data

0.09% -0.12%
of RGC is owned by hedge funds
8.49K -11.74K
shares is hold by hedge funds
  • What's the price of Regencell Bioscience Holdings Limited stock today?

    One share of Regencell Bioscience Holdings Limited stock can currently be purchased for approximately $12.31.

  • When is Regencell Bioscience Holdings Limited's next earnings date?

    Unfortunately, Regencell Bioscience Holdings Limited's (RGC) next earnings date is currently unknown.

  • Does Regencell Bioscience Holdings Limited pay dividends?

    No, Regencell Bioscience Holdings Limited does not pay dividends.

  • How much money does Regencell Bioscience Holdings Limited make?

    Regencell Bioscience Holdings Limited has a market capitalization of 62.72M.

  • What is Regencell Bioscience Holdings Limited's stock symbol?

    Regencell Bioscience Holdings Limited is traded on the NASDAQ under the ticker symbol "RGC".

  • What is Regencell Bioscience Holdings Limited's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Regencell Bioscience Holdings Limited?

    Shares of Regencell Bioscience Holdings Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Regencell Bioscience Holdings Limited have?

    As Jul 2024, Regencell Bioscience Holdings Limited employs 12 workers.

  • When Regencell Bioscience Holdings Limited went public?

    Regencell Bioscience Holdings Limited is publicly traded company for more then 4 years since IPO on 16 Jul 2021.

  • What is Regencell Bioscience Holdings Limited's official website?

    The official website for Regencell Bioscience Holdings Limited is regencellbioscience.com.

  • How can i contact Regencell Bioscience Holdings Limited?

    Regencell Bioscience Holdings Limited can be reached via phone at +852 2155 0823.

Regencell Bioscience Holdings Limited company profile:

Regencell Bioscience Holdings Limited

regencellbioscience.com
Exchange:

NASDAQ

Full time employees:

12

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

First Commercial Building
Causeway Bay, KY1-1107

CIK: 0001829667
ISIN: KYG7487R1002
CUSIP: G7487R100